Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease (SAPHIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02389413
Recruitment Status : Completed
First Posted : March 17, 2015
Last Update Posted : June 1, 2017
Julius Clinical, The Netherlands
VU University Medical Center
Information provided by (Responsible Party):
Probiodrug AG